MedPath

A Potential Role for Oxygen in the Development of Mental Fatigue and the Subsequent Decline in Cognitive Performance

Not Applicable
Conditions
Near Infrared Spectroscopy
NIRS
Mental Fatigue
Hypoxia
Cognition
Cerebral Heamodynamics
Interventions
Other: Hypoxia
Other: Normoxia
Registration Number
NCT05100667
Lead Sponsor
Vrije Universiteit Brussel
Brief Summary

Introduction Both Mental Fatigue (MF) and hypoxia impair multiple aspects of cognitive functioning. The decline in cognitive functioning in hypoxic conditions is associated with alterations in brain oxygenation and hemodynamic responses. These hemodynamic responses are preferably measured at the prefrontal cortex, an area of the brain that is known for its executive function and role in decision making, planning, attention and (short-term) memory. This study will investigate the role of prefrontal cortex oxygenation during the development of mental fatigue and during cognitive performances by altering the ambient oxygen availability through normobaric hypoxia (3800m; 12,9% O2) and normoxia.

Methods Subjects will perform four trials in a sound-insulated climate chamber (20°C and 40% RH). Upon entry in the climatic chamber participants will adapt to the environment for 30 minutes. Next, they will perform a modified cognitive test battery "cognition", a fine motor task "Motor Performance Series" and a visuomotor-fitlight task before and after a 60-minute individualized Stroop task or control task (randomized. blinded, placebo controlled, counter-balanced, cross-over design). Nearinfrared spectroscopy (NIRS) will be used to assess hemodynamic changes (oxygenated hemoglobin (O2Hb), deoxygenated-hemoglobin (HHb) and total hemoglobin (tHb)) at the PFC.

Hypotheses 1) MF will lead to earlier changes in the prefrontal NIRS-parameters (O2Hb, HHb, tHb) with lower oxygen availability. 2) The effects of MF on cognitive performance manifest itself to a greater extent with lower oxygen availability.3) Visuomotor performance declines to a greater extent due to MF with lower oxygen availability.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
15
Inclusion Criteria
  • Healthy (No neurological or cardiovascular disorders)
  • Male or female
  • No medication
  • Non-smoker
  • Between 18 and 35 years old
  • Recreational athlete population; performance level 2 or 3 for men according to De Pauw et al. (2013)[29] and performance level 2 or 3 for woman according to Decroix et al. (2015)
  • Non-acclimatized to altitude (at least 2 months)
Exclusion Criteria
  • Injuries
  • Acclimated to altitude
  • Use of medication
  • Use of caffeine and heavy efforts 24 hours prior each trial
  • Not eating a standardized meal, the morning of each trial

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Control MFNormoxiaEmotionally neutral documentary
Control MFHypoxiaEmotionally neutral documentary
Mental fatigueNormoxiaStroop task
Mental fatigueHypoxiaStroop task
Primary Outcome Measures
NameTimeMethod
Cerebral oxygenation2 hours

Prefrontal cortex oxygenation = relative changes in oxy- and deoxy hemoglobin at the prefrontal cortex. During the whole frame, participants are equipped with a Near Infrared Spectroscopy device that measures cerebral oxygenation continuously at 10hz.

Mental fatigue60 minutes

Results of a visual analogue scale for mental fatigue

Secondary Outcome Measures
NameTimeMethod
Fine motor control5 minutes

Results of the vienna test system (MLS) =accuraccy and reaction time

Visuomotor control7 minutes

Results of a visuomotor fitlight task = accuracy and reaction time

Cognition20 minutes

Results of the Joggle cognition test battery (accuracy and reaction time

Trial Locations

Locations (1)

Human Physiology - MFYS

🇧🇪

Brussels, Belgium

© Copyright 2025. All Rights Reserved by MedPath